Phillip David Monk,Lutz Jermutus,Celia Patricia Shorrock,Ralph Raymond Minter
申请号：
US15058612
公开号：
US09856317B2
申请日:
2016.03.02
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Specific binding members, in particular human anti-IL-13 antibody molecules and especially those which neutralize IL-13 activity. Methods for using anti-IL-13 antibody molecules in diagnosis or treatment of IL-13 related disorders, including asthma, atopic dermatitis, allergic rhinitis, fibrosis, inflammatory bowel disease and Hodgkin's lymphoma.
